If you fall in that BMI of 30 or more range, or have a BMI of 27 with a weight-related comorbidity, thats when your doctor might consider a GLP-1
Liu J, Mai K, Xu W, Zhang Y, Zhou H, Ai Q
doi: 10.1093/nutrit/nuu011
In three nested casecontrol studies from England and Wales, involving 440,089 patients with T2DM and without ASCVD treated with non-insulin glucose-lowering medication, combined SGLT2i and GLP-1RA therapy used for primary prevention was associated with 30% lower odds of MACE (defined as myocardial infarction/acute coronary syndrome, stroke/transient ischemic attack, and/or cardiovascular death) compared with other combination regimens (OR, 0.70
They can help you find the best approach tailored to your needs, ensuring you get the most benefit from semaglutide and omeprazole